“…In contrast with Ca V 2.1 null mice, Ca V 2.2 deficiency leads to only mild consequences, which include reduced pain hypersensitivity in models of inflammatory and neuropathic pain (Hatakeyama et al, 2001;Kim et al, 2001a;Saegusa et al, 2001), hyperactivity (Beuckmann et al, 2003), reduced anxiety (Saegusa et al, 2001), a reduction of voluntary alcohol intake (Newton et al, 2004), and problems with blood pressure control . The effects of Ca V 2.2 channel deletion on pain are consistent with the notion that Ca V 2.2 channels are critical for neurotransmitter release from afferent terminals in the spinal dorsal horn (for review, see Bourinet et al, 2014), and these findings validate Ca V 2.2 channels as potential targets for analgesics.…”